ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Statistics

Total Valuation

ALXO has a market cap or net worth of $74.28 million. The enterprise value is $29.26 million.

Market Cap	74.28M
Enterprise Value	29.26M

Important Dates

The last earnings date was Friday, November 7, 2025, before market open.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

ALXO has 54.22 million shares outstanding. The number of shares has increased by 5.27% in one year.

Current Share Class	54.22M
Shares Outstanding	54.22M
Shares Change (YoY)	+5.27%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	2.76%
Owned by Institutions (%)	22.51%
Float	29.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.64
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.35.

Current Ratio	2.40
Quick Ratio	2.20
Debt / Equity	0.35
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-65.88

Financial Efficiency

Return on equity (ROE) is -118.95% and return on invested capital (ROIC) is -63.17%.

Return on Equity (ROE)	-118.95%
Return on Assets (ROA)	-50.49%
Return on Invested Capital (ROIC)	-63.17%
Return on Capital Employed (ROCE)	-197.16%
Revenue Per Employee	n/a
Profits Per Employee	-$1.35M
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.93% in the last 52 weeks. The beta is 0.53, so ALXO's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-9.93%
50-Day Moving Average	1.58
200-Day Moving Average	0.92
Relative Strength Index (RSI)	46.34
Average Volume (20 Days)	341,270

Short Selling Information

The latest short interest is 1.78 million, so 3.28% of the outstanding shares have been sold short.

Short Interest	1.78M
Short Previous Month	1.84M
Short % of Shares Out	3.28%
Short % of Float	6.13%
Short Ratio (days to cover)	4.41

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-108.44M
Pretax Income	-108.01M
Net Income	-108.01M
EBITDA	-107.67M
EBIT	-108.44M
Earnings Per Share (EPS)	-$2.01

Balance Sheet

The company has $60.63 million in cash and $15.61 million in debt, giving a net cash position of $45.02 million or $0.83 per share.

Cash & Cash Equivalents	60.63M
Total Debt	15.61M
Net Cash	45.02M
Net Cash Per Share	$0.83
Equity (Book Value)	44.80M
Book Value Per Share	0.84
Working Capital	38.79M

Cash Flow

In the last 12 months, operating cash flow was -$97.21 million and capital expenditures -$223,000, giving a free cash flow of -$97.43 million.

Operating Cash Flow	-97.21M
Capital Expenditures	-223,000
Free Cash Flow	-97.43M
FCF Per Share	-$1.80

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALXO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.27%
Shareholder Yield	-5.27%
Earnings Yield	-145.41%
FCF Yield	-131.17%

Analyst Forecast

The average price target for ALXO is $3.30, which is 142.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.30
Price Target Difference	142.65%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2